Top Markets
Coin of the day
Tetra Bio-Pharma Inc. Tetra Bio-Pharma Inc.

Tetra Bio-Pharma Inc.

TBP
Rank in Stocks #35576
Headquartered in OrlΓ©ans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in OrlΓ©ans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Share Price
$0.01851783
Last synced: 2023-05-23
Market Cap
$3.71M
Change (1 day)
-0.04%
Change (1 year)
0.00%
Country
CA
Trade Tetra Bio-Pharma Inc. (TBP)

Category

Number of shares outstanding for Tetra Bio-Pharma Inc. (TBP)
Number of shares outstanding as of August 2026: 0
According to Tetra Bio-Pharma Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Tetra Bio-Pharma Inc. (TBP) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
- -
CH
- -
KR
0.00 -
BE